Published in Am J Psychiatry on August 01, 2007
A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry (2010) 5.00
Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry (2009) 3.94
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol (2009) 3.52
Does fetal exposure to SSRIs or maternal depression impact infant growth? Am J Psychiatry (2013) 2.19
A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry (2013) 2.12
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry (2009) 2.01
Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand (2012) 1.75
Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. Early Hum Dev (2012) 1.52
Elevated midpregnancy corticotropin-releasing hormone is associated with prenatal, but not postpartum, maternal depression. J Clin Endocrinol Metab (2008) 1.32
Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements. Epigenetics (2012) 1.25
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry (2008) 1.22
Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci (2008) 1.22
Neonatal DNA methylation patterns associate with gestational age. Epigenetics (2011) 1.22
The social determinants of infant mortality and birth outcomes in Western developed nations: a cross-country systematic review. Int J Environ Res Public Health (2013) 1.19
Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology (2012) 1.18
Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl) (2011) 1.08
Low birth weight in offspring of women with depressive and anxiety symptoms during pregnancy: results from a population based study in Bangladesh. BMC Public Health (2010) 1.01
Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature. J Matern Fetal Neonatal Med (2013) 0.98
Mother-infant antidepressant concentrations, maternal depression, and perinatal events. J Clin Psychiatry (2011) 0.98
A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. J Clin Psychiatry (2011) 0.98
Maternal depressive symptoms, depression, and psychiatric medication use in relation to risk of preterm delivery. Womens Health Issues (2009) 0.97
Prenatal depression effects and interventions: a review. Infant Behav Dev (2010) 0.96
Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety (2011) 0.96
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict (2010) 0.95
The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Front Cell Neurosci (2013) 0.94
The relationship between women's attachment style and perinatal mood disturbance: implications for screening and treatment. Arch Womens Ment Health (2008) 0.93
Preconception care: screening and management of chronic disease and promoting psychological health. Reprod Health (2014) 0.92
Risk of spontaneous preterm birth in relation to maternal depressive, anxiety, and stress symptoms. J Reprod Med (2013) 0.92
The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) (2013) 0.92
Association of maternal prenatal depressive symptoms with child cognition at age 3 years. Paediatr Perinat Epidemiol (2010) 0.90
Do the PHQ-8 and the PHQ-2 accurately screen for depressive disorders in a sample of pregnant women? Gen Hosp Psychiatry (2010) 0.89
Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS One (2014) 0.89
The simplified Edinburgh Postnatal Depression Scale (EPDS) for antenatal depression: is it a valid measure for pre-screening? Int J Med Sci (2011) 0.89
Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction. J Clin Psychopharmacol (2009) 0.88
Acculturation, depressive symptoms, estriol, progesterone, and preterm birth in Hispanic women. Arch Womens Ment Health (2012) 0.87
The utility of screening for perinatal depression in the second trimester among Chinese: a three-wave prospective longitudinal study. Arch Womens Ment Health (2010) 0.87
Prenatal depression and adverse birth outcomes: an updated systematic review. Matern Child Health J (2015) 0.87
Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol (2013) 0.85
Perinatal depression: implications for child mental health. Ment Health Fam Med (2010) 0.84
Associations of maternal psychological factors with umbilical and uterine blood flow. J Psychosom Obstet Gynaecol (2011) 0.83
A pilot randomised controlled trial of cognitive behavioural therapy for antenatal depression. BMC Psychiatry (2013) 0.83
Saliva estriol levels in women with and without prenatal antidepressant treatment. Biol Psychiatry (2008) 0.82
Maternal corticotropin-releasing hormone and the use of selective serotonin reuptake inhibitors independently predict the occurrence of preterm birth. J Midwifery Womens Health (2011) 0.81
Uterine blood flow in a psychiatric population: impact of maternal depression, anxiety, and psychotropic medication. Biol Psychiatry (2012) 0.80
No association between antenatal common mental disorders in low-obstetric risk women and adverse birth outcomes in their offspring: results from the CDS study in Ghana and Côte D'Ivoire. PLoS One (2013) 0.79
Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis. PLoS One (2015) 0.78
Association between depressive symptoms in adolescence and birth outcomes in early adulthood using a population-based sample. Prev Med Rep (2015) 0.77
Antenatal Depression is Not Associated with Low-Birth Weight: A Study from Urban Pakistan. Front Psychiatry (2014) 0.77
Limited Depressive and Anxiety Symptoms Late in Pregnancy Are Not Related to Neonatal Outcomes. Nurs Midwifery Stud (2015) 0.77
Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges. Drug Healthc Patient Saf (2014) 0.76
Depression status as a confounder in the effects of antidepressants on the gestation age. Am J Psychiatry (2008) 0.75
Effects of maternal psychotropic drug dosage on birth outcomes. Neuropsychiatr Dis Treat (2013) 0.75
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA (2006) 6.48
Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry (2006) 5.30
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2009) 2.80
Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up. Am J Psychiatry (2015) 2.80
The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol Psychiatry (2002) 2.70
Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. Am J Psychiatry (2011) 2.47
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry (2007) 2.45
Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv (2006) 2.34
Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatr Serv (2006) 2.31
Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. JAMA Psychiatry (2013) 2.24
Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging (2004) 2.23
Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. J Consult Clin Psychol (2003) 2.20
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry (2008) 2.17
Consistency of Brief Psychiatric Rating Scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology (2007) 2.01
Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res (2007) 1.98
White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol (2003) 1.93
Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiol Aging (2008) 1.92
Is emotion processing a predictor of functional outcome in schizophrenia? Schizophr Bull (2003) 1.89
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging (2006) 1.87
Increased amygdala activation during mania: a functional magnetic resonance imaging study. Am J Psychiatry (2005) 1.84
Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol (2003) 1.83
Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuse. Bipolar Disord (2009) 1.82
Bipolar II postpartum depression: Detection, diagnosis, and treatment. Am J Psychiatry (2009) 1.79
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull (2007) 1.72
Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry (2004) 1.72
Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry (2002) 1.71
From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry (2012) 1.68
Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord (2011) 1.67
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res (2007) 1.63
Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry (2004) 1.62
Schizophrenia as one extreme of a sexually selected fitness indicator. Schizophr Res (2004) 1.61
Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull (2011) 1.56
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry (2009) 1.55
A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia. Am J Psychiatry (2002) 1.55
Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002. J Clin Psychopharmacol (2007) 1.54
Blunted activation in orbitofrontal cortex during mania: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 1.44
Management of major depression during pregnancy. Am J Psychiatry (2002) 1.43
DSM-V: modifying the postpartum-onset specifier to include hypomania. Arch Womens Ment Health (2010) 1.38
Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull (2011) 1.38
Longitudinal follow-up of children with autism receiving targeted interventions on joint attention and play. J Am Acad Child Adolesc Psychiatry (2012) 1.37
Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology (2007) 1.33
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry (2007) 1.32
Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord (2005) 1.32
Neuropsychological deficits among patients with late-onset minor and major depression. Arch Clin Neuropsychol (2003) 1.30
Focal subcortical biophysical abnormalities in patients diagnosed with type 2 diabetes and depression. Arch Gen Psychiatry (2009) 1.29
A videotape intervention to enhance the informed consent process for medical and psychiatric treatment research. Am J Psychiatry (2005) 1.29
Computer-assisted self-assessment in persons with severe mental illness. J Clin Psychiatry (2004) 1.28
Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophr Res (2004) 1.27
Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology (2006) 1.27
Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction (2010) 1.27
Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. J Affect Disord (2007) 1.26
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry (2003) 1.25
Neuropsychiatric predictors of return to work in HIV/AIDS. J Int Neuropsychol Soc (2007) 1.25
Regional brain changes in bipolar I depression: a functional magnetic resonance imaging study. Bipolar Disord (2008) 1.25
Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry (2006) 1.24
Improving informed consent: the medium is not the message. IRB (2004) 1.23
Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry (2006) 1.22
Gray matter prefrontal changes in type 2 diabetes detected using MRI. J Magn Reson Imaging (2008) 1.22
Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry (2002) 1.22
Brain maturation may be arrested in chronic cocaine addicts. Biol Psychiatry (2002) 1.20
Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend (2012) 1.20
Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res (2011) 1.20
Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology (2011) 1.18
Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Arch Gen Psychiatry (2005) 1.16
Multimodal magnetic resonance imaging assessment of white matter aging trajectories over the lifespan of healthy individuals. Biol Psychiatry (2012) 1.15
Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. Am J Psychiatry (2013) 1.15
Conducting empirical research on informed consent: challenges and questions. IRB (2004) 1.14
Disease management in Latinos with schizophrenia: a family-assisted, skills training approach. Schizophr Bull (2003) 1.13
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry (2006) 1.13
In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res (2009) 1.12
Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry (2003) 1.12
Impaired inter-hemispheric integration in bipolar disorder revealed with brain network analyses. Biol Psychiatry (2012) 1.11
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Visual masking as a probe for abnormal gamma range activity in schizophrenia. Biol Psychiatry (2003) 1.10
Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement (2007) 1.10
Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease. J Alzheimers Dis (2004) 1.09
Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol Psychiatry (2005) 1.09
Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry (2007) 1.08
A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia. Schizophr Bull (2012) 1.07
Impaired implicit learning in schizophrenia. Neuropsychology (2008) 1.07
Stressful life events in recent-onset schizophrenia: reduced frequencies and altered subjective appraisals. Schizophr Res (2005) 1.06
Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Transplant (2008) 1.06
Forward and backward visual masking in unaffected siblings of schizophrenic patients. Biol Psychiatry (2005) 1.05
Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry (2002) 1.05
Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry (2003) 1.05
Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord (2007) 1.05
Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord (2005) 1.05
Prefrontal brain morphology and executive function in healthy and depressed elderly. Int J Geriatr Psychiatry (2009) 1.04
Bipolar pharmacotherapy and suicidal behavior Part 2. The impact of antidepressants. J Affect Disord (2007) 1.04
Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics. J Affect Disord (2007) 1.04
A network-based system to improve care for schizophrenia: the Medical Informatics Network Tool (MINT). J Am Med Inform Assoc (2004) 1.04
Applications of errorless learning for improving work performance in persons with schizophrenia. Am J Psychiatry (2002) 1.03
The cultural adaptability of intermediate measures of functional outcome in schizophrenia. Schizophr Bull (2010) 1.02
Sex differences in brain structure in geriatric depression. Am J Geriatr Psychiatry (2004) 1.02
Extensions of errorless learning for social problem-solving deficits in schizophrenia. Am J Psychiatry (2005) 1.02
Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits. Schizophr Res (2004) 1.02